REM (Zarcone et al 1987; Kempenaers et nl 1988) . We ~dertook the foHo~g retrospecfive analysis of our schizophrenia-sleep data base, comparing patients who experienced SOREM periods with those who ~ not to see whether the groups showed differences in clinical presentation, sleep variables, or prognosis.
Methods
The sample consisted of 36 schizophrenic inpatients (mean age = 28.6 _+ 7.7, range 19-47) diagnosed by SADS/RIX~ and DSM-~ criteria who gave informed consent to participate in the study. After a minimum of 2 weeks free of medication, they underwent two consecutive nights of sleep EEG studies in their own hospital beds, with the first night for adaptation and to rule out any ~ sleep dis. turbance, such as sleep apnea. Data from the second .njg.ht ovJy we~ u~d m ~e ~,-_--a!ysis. Patients were clinically screened to exclude those with signs of narcolepsy, and staff prevented patients from napping on the days when sleep studies were performed. Placement of electrodes and scoring were in accord with the methods described by Rechtschaffen and Kales (1968) . Sleep onset was defined as the first minute of stage 2 sleep followed by at least 10 rain of stage 2 sleep not interrupted by more than 2 rain awake or in stage 1. REM latency was defined as the time between sleep onset and the occurrence of the first REM period of at least 3 rain duration, minus intervening time awake (RLMA).
Brief Repmts
Once during the medication-free period and once after 4 weeks of treatment with 8-30 mg haloperidol equivalents, patients were assessed by the Brief Psychiatric Rating Scale (BPRS), the Scale for the Assessment of Negative Symptoms (SANS), and the Hamilton Rating Scale for Depression (HRSD, 17 item). One-year follow-up was done on 27 patients and scored according to the Strauss-Carpenter Outcome Scale (Strauss and Carpenter 1972) .
Results
Of the 36 patients, 6 (16.7%) experienced REM latency less than l0 min and I experienced a REM latency between l0 and 20 min. As seen in Figure  l , u~e distribution of REM iatencies suggests a bim~'~lal distribution. Using the strict definition of SO.~F.M ~ REM onset < 10 rain, we have compared these 6 patients with SOREM with the remaining ~0 patients with RL~ ~> 10 rain.
The SOREM and the non-SO~ ~p did not differ significantly in age at the time of the study or at the onset of illness, duration of iflness, number of hospitalizations, education, sex distribution, or subtype distribution (Table 1) . Only 1 patient in the SOREM group had never been on medication, and of those who had been, 2 of 5 had been medication-free for more tha~ 4 weeks, compared with 9 of 15 in the non-SO V~EM group. Two-way analysis of variance (ANOVA) of rating scales (Table !) , with pretreatment and posttreatment scales as repeated measures, revealed a strong group effect for SANS scores (df = 1,34, p < 0.005). Post hoc t-test with degrees of freedom corrected for the disparity in sample sizes (Glantz 1987) showed greater negative symptoms pretre~tment and posttreatmerit in the SOREM ,oroup. We found a group effect for BPRS total scores (df = !,34, p = 0.05), but these scores did not differ by post hoe t-test. BPRS positive subscales (conceptual disorganization, suspiciousness, hallucinatory behavior, and unusual thought content) and HR~D scotes did not differ between the groups. AN-OVA also revealed a very strong treatment effect for all scales (df = 1,34, p < 0.0001), and no treatmentby group interaction, indicating that both groups improved equally with treatment. On the Suauss-Ca~enter Outcome Sca~e, the SOREM group had significantly tmot~ global functioning at 1 year by Student's t-test. ther of these factors ap~ to be operative with our patients. One has to consider the possible effects of neuroleptic withdrawal with only a 2-week washout period, although half of our SOREM patients had either never been on psychotropics or had been withdrawn for more than 4 weeks.
Analysis of sleep v~iables was by
SOREM periods in our schizophrenic patients have relatively short durations when compared with SOREMs in depressives, which tend to be long (Ansseau et al I984), e~cept when psychosis accompanies the depression (Thase et al 1986; Ganguli et al 1987) . Schizophrenic patients with SOREM, compar~ ".,,'i~ those without SOREM, had a shorter first REM period, more negative syn~oms both before and ~ _,j~~t_ ~_mi poorer global functioning at 1 year. SOREMs may simply indicate greater overall severity (higher pretreatment BPRS and SANS scores and poor outcome), and that would be consistent with the demonstrated association between shortened REM latency (Tandon et al 1989) and the poor outcome associated with negative symptoms in schizophrenia (Andreasen 1982) . After neuroleptic Ucaunent, the major differences occur in ratings of negative symptoms, suggesting that additional reseerch examine the links between persistent negative symptomatology and neurotransmitter mechanisms involved in the control of REM sleep onset and duration.
